News - STADA Arzneimittel

Filter

Current filters:

STADA Arzneimittel

Popular Filters

Solid financials from Stada but outlook sends stock down

Solid financials from Stada but outlook sends stock down

25-03-2014

German generic and branded drugmaker Stada Arzneimittel posted a solid set of financial results for 2013,…

FinancialGenericsSTADA Arzneimittel

Stada Arz expands biosimilars range, in-licensing Grastofil from Apotex

Stada Arz expands biosimilars range, in-licensing Grastofil from Apotex

30-10-2013

German generic and branded drugmaker Stada Arzneimittel says it has strengthened its activities in the…

AmgenApotexBiosimilarsEuropeGrastofilHematologyLicensingNeupogenSTADA Arzneimittel

Stada Arz buys UK OTC manufacturer

21-08-2013

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Generic launches by Mylan, Stada Arz and Dr Reddy's

27-06-2013

US copy drugs maker Mylan (NYSE: MYL) has launched norethindrone tablets USP, 0.35 the generic version…

Dr Reddy's LaboratoriesEuropeGenericsLamictal XRMarkets & MarketingMen's HealthMicronorMylan LaboratoriesNeurologicalNorth AmericaReproductiveSTADA ArzneimittelViagra

Stada Arz takes top active ingredients in AOK tender round

12-02-2013

Following 18 awards in the tenth tender round of the Allgemeine Ortskrankenkasse (AOK) in the middle…

EuropeFinancialGenericsMarkets & MarketingSTADA Arzneimittel

Stada Arz extends generics deal with Omega Pharma; Omega appointments

03-02-2013

German drugmaker Stada Arzneimittel's (SAZ: GR) Belgian subsidiary, Eurogenerics, and the pharmaceutical…

EuropeGenericsManagementMarkets & MarketingOmega PharmaPharmaceuticalSTADA Arzneimittel

Good start to 2013 for Stada Arz in German tender process

27-01-2013

German drugmaker Stada Arzneimittel's (SAZ: GR) sales companies- STADApharm and ALIUD Pharma - have also…

EuropeFinancialGenericsMarkets & MarketingSTADA Arzneimittel

Stada Arz takes a leading position in the third Barmer GEK discount round

19-09-2012

German branded and generic drugmaker Stada Arzneimittel (SAZ: GR) says that its sales companies have…

EuropeFinancialGenericsMarkets & MarketingPharmaceuticalSTADA Arzneimittel

Stada Arz sells two Russian production facilities

16-08-2012

German drugmaker Stada Arzneimittel (SAZ: GR) revealed this week that it has signed a contract and accompanying…

EuropeGenericsMergers & AcquisitionsPharmaceuticalProductionSTADA Arzneimittel

Stada Arz first-half 2012 sales rise 7%

08-08-2012

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) reported first-half 2012 financial…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Novo Nordisk and AstraZeneca among firms to invest in Russian pharma hub

11-07-2012

In Russia, the Kaluga government plans to establish a pharmaceutical manufacturing hub in the region…

AstraZenecaEuropeFinancialMarkets & MarketingMenariniNovo NordiskPharmaceuticalSTADA Arzneimittel

Stada Arz sales companies do well in German generics market tenders

29-05-2012

The executive board of German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) believes that…

EuropeFinancialGenericsMarkets & MarketingSTADA Arzneimittel

Stada Arz reports solid start to 2012

10-05-2012

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) reported first-quarter 2012 financial…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Stada Arz viewing optimization of Russian operations

23-04-2012

German pharmaceutical producer Stada Arzneimittel is considering optimizing its Russian operations through…

EuropeFinancialGenericsMarkets & MarketingPharmaceuticalSTADA Arzneimittel

STADA Arz sets up subsidiary in Australia

27-03-2012

German generics drugmaker STADA Arzneimittel (SAZ: GR) has established a subsidiary based in Sydney,…

Asia-PacificGenericsMarkets & MarketingSTADA Arzneimittel

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

STADA pulls out of part of Grunenthal deal

04-01-2012

German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties

11-11-2011

German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerland’s Spirig Pharma…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSpirig PharmaSTADA Arzneimittel

Ipsen sells North American rights for Apokyn to Britannia Pharma

03-11-2011

French drugmaker Ipsen (Euronext: IPN) today has sold its North American development and marketing rights…

ApokynBritannia PharmaceuticalsIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSTADA Arzneimittel

Germany’s Stada Arz warns of risk of Serbian default

22-09-2011

German drugmaker Stada Arzneimittel (STAGn: DE) has warned that the outstanding receivables due to its…

FinancialGenericsHemofarmSTADA Arzneimittel

Good first-half results from Stada Arz driven by branded and generic drugs

11-08-2011

German drugmaker Stada Arzneimittel reported first-half 2011 results with 7% growth in group sales to…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Back to top